Ticker Details
Pacific Biosciences of California, Inc. Pacific Biosciences of California Inc is a biotechnology company. It is engaged in design, development, and manufacture of sequencing system to help scientists resolve genetically complex problems.
IPO Date:	October 27, 2010
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$465.9M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.26 | 3.64%
Avg Daily Range (30 D):	$0.06 | 3.87%
Avg Daily Range (90 D):	$0.05 | 3.71%

Institutional Daily Volume
Avg Daily Volume:	2.83M
Avg Daily Volume (30 D):	5.62M
Avg Daily Volume (90 D):	5.6M

Trade Size
Avg Trade Size (Sh.):	207
Avg Trade Size (Sh.) (30 D):	342
Avg Trade Size (Sh.) (90 D):	366

Institutional Trades
Total Institutional Trades:	4,450
Avg Institutional Trade:	$2.15M
Avg Institutional Trade (30 D):	$1.51M
Avg Institutional Trade (90 D):	$1.13M
Avg Institutional Trade Volume:	.24M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.23M
Avg Closing Trade (30 D):	$1.41M
Avg Closing Trade (90 D):	$1.08M
Avg Closing Volume:	353.49K

News

Apr 29, 2026 @ 5:00 PM Global Metagenomics Sequencing Market to Register ... Source: Delveinsight

Apr 24, 2026 @ 8:59 AM Omics-Based Clinical Trials Research Report 2026: ... Source: Researchandmarkets.Com

Apr 7, 2026 @ 5:44 PM Global DNA Read, Write and Edit Market to Surge to... Source: Bcc Research

Oct 31, 2025 @ 7:15 AM Genomics Data Analysis Market Size to Surpass USD ... Source: Nova One Advisor

Aug 6, 2025 @ 1:00 PM PacBio to Present at Upcoming Investor Conferences... Source: Pacbio

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.43	$-.03	$-.13
Diluted EPS	$-.43	$-.03	$-.13
Revenue	$160.03M	$37.18M	$44.65M
Gross Profit	$59.99M	$12.84M	$16.57M
Net Income / Loss	$-128.58M	$-8.28M	$-40.37M
Operating Income / Loss	$-133.28M	$-8.36M	$-41.2M
Cost of Revenue	$100.04M	$24.34M	$28.08M
Net Cash Flow	$-2.87M	$-7.4M	$6.96M
PE Ratio